Starling Oncology, Inc. (STLN)

6.19 -0.01 (-0.16%) USD  |  NASDAQ  |  Sep 11, 10:47
More

Starling Oncology Cash from Operations (Annual) : -24.59M for Dec. 31, 2025

Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for STLN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 -24.59M
December 31, 2024 -26.54M
December 31, 2023 -36.32M
December 31, 2022 -61.76M
Date Value
December 31, 2021 -32.68M
December 31, 2020 0.508M
December 31, 2019 0.00

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Astrana Health, Inc. 114.60M
Agilon Health, Inc. -105.76M
Nakamoto, Inc. -23.51M
American Oncology Network, Inc. --
Sonida Senior Living, Inc. 24.36M